NCI Explores AI to Screen For and Treat Pancreatic Cancer
The institute sees the emerging technology supporting treatment for patients by better controlling tumor growth.
A new initiative at the National Cancer Institute aims to create capabilities for detecting pancreatic cancer early and improving treatments for patients with mutations.
A big challenge with pancreatic cancer resides in the KRAS gene. When mutated, the gene can cause normal cells to become cancerous. A new therapy involving KRAS inhibitors and genetic testing can help patients screen for this earlier.
Dr. Christine Alewine, the NIH Lasker Scholar in the Laboratory of Molecular Biology at NCI’s Center for Cancer Research, discussed this breakthrough, how new advancements can serve as an alternative treatment for chemotherapy and where AI can make an impact. Plus, she notes how other health issues such as diabetes also plays a role in screening for pancreatic cancer.
-
Dr. Christine Alewine NIH Lasker Scholar in the Laboratory of Molecular Biology, Center for Cancer Research NCI
-
How Integrated Analytics Can Break Federal Data Silos
The Coleridge Initiative is leading the charge to modernize government data management, breaking down bureaucratic barriers by providing secure data access, advanced analytics and cross-agency collaboration tools.
11m watch -
AI Revolutionizes Defense Decision-Making
AI enhances access to vital information for defense leaders, empowering faster, more informed decision-making on and off the battlefield.
20m watch -
Opinion: How International Partners Might Drive US AI Development
Recent deals with Saudi Arabia, UAE and Qatar signal a new era of geopolitics where technology defines global power and alliances.
7m read -
DISA Harnesses AI to Fortify Cyber Resilience
Brig. Gen. Michael Cornell details how automated alerts and responses enhance network stability and user experience.
11m watch
